Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology

3 years ago

For the third straight year, Lumenis wins award recognizing outstanding medical companies and technologies YOKNE’AM ILLIT, Israel--(BUSINESS WIRE)--Lumenis Be., a…

American Family Care Names New Vice President of Franchise Development

3 years ago

Nation's Largest Urgent Care Provider Appoints Paige Robinson to Lead Expansion EffortsBIRMINGHAM, AL / ACCESSWIRE / May 25, 2022 /…

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS

3 years ago

The three-year $2.97 million Phase 2 STTR Study Grant through the NIH HEAL Initiative (Helping End Addiction Long-term) is providing…

AlzeCure Presents at Redeye Growth Day on June 2

3 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / May 25, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

Jaguar Health Announces Napo Therapeutics’ Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition

3 years ago

Microvillus inclusion disease (MVID) is a life-threatening and rare autosomal recessive disease that affects newborns and children and leads to…

CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

3 years ago

CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology…

Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update

3 years ago

Progressing broad vaccine development program in collaboration with GSK, with second-generation candidates in Phase 1 clinical trials for COVID-19 and…

Tenon Medical, Inc. Announces Upcoming Virtual Conference Participation

3 years ago

LOS GATOS, CA / ACCESSWIRE / May 25, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device…

ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference

3 years ago

SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer,…

Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022

3 years ago

Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof…